Advances in the diagnosis of oral premalignant and malignant lesions.

Joel B. Epstein, Lewei Zhang, Miriam P. Rosin

PubMed · 2002 · 203 citations · 29 references

Concepts

TL;DR

The diagnosis and treatment of oral premalignant lesions and squamous cell carcinoma rely on histopathologic features, site, and disease stage, and clinicians should be aware of emerging diagnostic advances. This review examines recent advances in techniques for detecting lesions and predicting their progression or recurrence. Adjuncts such as toluidine blue vital staining and exfoliative cytology aid in lesion detection and biopsy site selection. Molecular‑level diagnostic and staging advances are expected to influence treatment choices and improve patient outcomes.

Abstract

The diagnosis and treatment of oral premalignant lesions and squamous cell carcinoma are currently based on histopathologic features, site of involvement and stage of disease. Recent advances in techniques for detecting lesions and predicting their progression or recurrence are reviewed here. Adjuncts for detection of lesions and selection of biopsy sites include vital tissue staining (with toluidine blue) and exfoliative cytology. Advances in diagnosis and staging at the molecular level are expected to affect choice of treatment and patient outcomes. Oral health care providers should be aware of these advances in the evaluation and diagnosis of oral premalignant lesions and squamous cell carcinoma.

References

29